62
Participants
Start Date
August 12, 2019
Primary Completion Date
August 12, 2024
Study Completion Date
August 12, 2024
BIIB094
Administered as specified in the treatment arm.
Placebo
Administered as specified in the treatment arm.
Neuro-SysMed Center, Bergen
St. Olav University Hospital, Trondheim
University of Pennsylvania, Philadelphia
Hospital General Universitario Gregorio Marañón, Madrid
Alliance for Multispecialty Research, Knoxville
The Cleveland Clinic Foundation, Cleveland
Quest Research Institute, Farmington Hills
Laboratorios de Investigación Biocruces 3., Hospital de Cruces, Barakaldo
Northwestern University PD and Movement Disorders Center, Chicago
Sourasky Medical Center, Tel Aviv
Oregon Health and Science University, Portland
Inland Northwest Research, Spokane
Research Site, Toronto
Research Site, Seville
Montreal Neurological Institute and Hospital, Montreal
Hospital General de Catalunya, Barcelona
Hospital Clinic de Barcelona, Barcelona
Queen Square (Neurology) CRF Site Institute of Neurology & the National Hospital for Neurology and Neurosurgery UCLH, London
Lead Sponsor
Ionis Pharmaceuticals, Inc.
INDUSTRY